Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Non-Current Assets (2022 - 2025)

Historic Non-Current Assets for 60 Degrees Pharmaceuticals (SXTP) over the last 4 years, with Q3 2025 value amounting to $380135.0.

  • 60 Degrees Pharmaceuticals' Non-Current Assets fell 2826.32% to $380135.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year decrease of 3272.81%. This contributed to the annual value of $373068.0 for FY2024, which is 3106.44% down from last year.
  • Latest data reveals that 60 Degrees Pharmaceuticals reported Non-Current Assets of $380135.0 as of Q3 2025, which was down 2826.32% from $337583.0 recorded in Q2 2025.
  • In the past 5 years, 60 Degrees Pharmaceuticals' Non-Current Assets registered a high of $1.7 million during Q2 2023, and its lowest value of $198202.0 during Q4 2022.
  • For the 4-year period, 60 Degrees Pharmaceuticals' Non-Current Assets averaged around $514960.8, with its median value being $380135.0 (2025).
  • In the last 5 years, 60 Degrees Pharmaceuticals' Non-Current Assets soared by 17304.62% in 2023 and then crashed by 6650.28% in 2024.
  • Over the past 4 years, 60 Degrees Pharmaceuticals' Non-Current Assets (Quarter) stood at $198202.0 in 2022, then soared by 173.05% to $541183.0 in 2023, then tumbled by 31.06% to $373068.0 in 2024, then rose by 1.89% to $380135.0 in 2025.
  • Its Non-Current Assets stands at $380135.0 for Q3 2025, versus $337583.0 for Q2 2025 and $327636.0 for Q1 2025.